Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Allogene Therapeutics (ALLO) Tax Provisions (2019)

Historic Tax Provisions for Allogene Therapeutics (ALLO) over the last 1 years, with Q4 2019 value amounting to -$131000.0.

  • Allogene Therapeutics' Tax Provisions changed N/A to -$131000.0 in Q4 2019 from the same period last year, while for Sep 2020 it was -$131000.0, marking a year-over-year change of. This contributed to the annual value of $443000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Allogene Therapeutics reported Tax Provisions of -$131000.0 as of Q4 2019.
  • Over the past 5 years, Allogene Therapeutics' Tax Provisions peaked at $33000.0 during Q3 2019, and registered a low of -$200000.0 during Q2 2019.